Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Percutaneous absorption o… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation

Artikel i vetenskaplig tidskrift
Författare Helena Gonzalez
A. Farbrot
Olle Larkö
Ann-Marie Wennberg
Publicerad i Br J Dermatol
Volym 154
Nummer/häfte 2
Sidor 337-40
ISSN 0007-0963 (Print)
Publiceringsår 2006
Publicerad vid Institutionen för kliniska vetenskaper
Sidor 337-40
Språk en
Länkar dx.doi.org/10.1111/j.1365-2133.2005...
Ämnesord Administration, Cutaneous, Adult, Benzophenones/administration & dosage/*pharmacokinetics/urine, Drug Administration Schedule, Female, Humans, Male, Radiation Dosage, Skin Absorption/*radiation effects, Sunscreening Agents/administration & dosage/*pharmacokinetics, *Ultraviolet Rays
Ämneskategorier Dermatologi och venereologi

Sammanfattning

BACKGROUND: Benzophenone-3 (BZ-3; 2-hydroxy-4-methoxybenzophenone, oxybenzone) is commonly used to absorb ultraviolet (UV) radiation. BZ-3 penetrates the skin and can be found in the urine. The amount varies between 0.4% and 2%. This seems to be the main metabolic pathway in rats. OBJECTIVES: To investigate the total amount of BZ-3 excreted in the urine after repeated topical whole-body applications of a sunscreen and to see if UV radiation has any effect on the amount excreted. METHODS: Twenty-five volunteers applied a commercially available sunscreen containing 4% BZ-3 morning and night for 5 days. Their urine was measured during those 5 days and during a further 5 days after the last application. They were divided into groups A (unirradiated) and B. Group B received UV radiation according to skin type: UVA between 400 and 707 J cm(-2), and UVB between 0.46 and 2.0 J cm(-2). BZ-3 in urine was analysed with a high-performance liquid chromatography method. RESULTS: The volunteers excreted 1.2-8.7% (mean 3.7%) of the total amount of BZ-3 applied. There was no significant difference between the two groups (P < 0.99, t-test). CONCLUSIONS: We show that a large amount of BZ-3 is absorbed. BZ-3 is accumulated in the body as the volunteers excreted BZ-3 5 days after the last application.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?